News and events2020-03-20T13:22:01+00:00

React4life in the global news

Primary cells are used in ADME and toxicology studies. Let’s find out how and why.

The main difference between primary cells and tumor cell lines is that the first are isolated directly from healthy human or animal tissues while others have normal diploid chromosomes and maintain much of the physiological properties of the tissue from which they are derived. During drug development, and before ever administering a new drug to a human patient, it’s necessary to predict how the drug might be metabolized in a healthy individual, and how that individual might adversely respond to the drug. The tumor cell lines make for poor predictors of how a healthy person may respond to a [...]

April 6th, 2020|

The demand of anti-pollution beauty products is growing in 2020

The beauty products with anti-pollution battling skin care are on the rise in markets. The increasing pollution levels, the deteriorating air quality, the depleting ozone layer and wider climate concerns, have all caused a huge shift in consumers’ attitude over the past few years. This is one of some reason that reflected in the new range of anti-pollution lines being churned out by almost every high-end skincare brand across the world today. A study by Neilson, a global data and research company, states, “anti-pollution creams and formulations are rising compared with overall skincare The main cause of pollution affects [...]

March 31st, 2020|

How is the study on the evaluation of alternative methods to animal testing going?

In Europe there is a commission, the EURL ECVAM which is an integral part of the JRC, JOINT RESEARCH CENTER which is located in Ispra, Italy. The mandate of EURL ECVAM is reported in the EU legislation relating to the protection of animals used in laboratories for scientific purposes. The purpose of the ECVAM team focuses on three crucial points, called the 3R: Replacement, Reduction and Refinement. All the activities carried out by EURL ECVAM are concentrated on the collaboration and support of international and EU research initiatives, on the coordination and implementation of validation studies of alternative methods [...]

March 27th, 2020|

Our CEO, Maurizio Aiello tells himself at the European Commission in an interview

The experience of the EU FET and MOOD projects, its expectations and goals, our CEO Maurizio Aiello tells himself at the European Commission in an interview Our CEO, Maurizio Aiello, was recently protagonist of an interview organized by the team of Teresa De Martino, Scientific Officer of the European Commission, whom we kindly thanks. From the educational to the professional path, Maurizio with sincerity tells himself in the "Interview with a FET Innovator in the service of oncology patient" , focusing on the experience of the European FET and MOOD projects, of his role as CEO for the our innovative [...]

March 19th, 2020|

React4life supports vaccine research program for COVID-19

About three months after the start of the coronavirus epidemic (COVID-19), over 170.000 confirmed cases of COVID-19 have been reported with over 6.600 deaths. The world of research is deeply involved to find therapies for all those who have contracted the coronavirus, and a vaccine that guarantees immunity to it. In response, the startup React4life launches a call for supporting all research teams actively involved in the therapies and vaccines technologies for the COVID-19 pandemic. All teams that access to the program will benefit from receiving: - free of charge MIVO® -Multi In Vitro Organ - devices for the culture of [...]

March 17th, 2020|

Hello Tomorrow Bussines day on videocall

Today we should have been at Hello Tomorrow in Paris but due to the recent outbreak of the #Coronavirus #COVID-19, the event was postponed at 21-23rd of October 2020. However, the Hello Tomorrow team gave us the opportunity to participate in the “Business Day" and meet very interesting companies. Thanks for letting us develop interesting business opportunities. See you in October!  

March 13th, 2020|

Get in Touch

We’d love to hear from you.

Stay updated
Stay updated
Buy Our products
buy our products